Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target

Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target

Acute Myeloid Leukemia (AML) is currently diagnosed based on morphological assessment of myeloid cells’ features, immunophenotypic characterization of specific cell surface and intracellular markers, conventional cytogenetic testing and screening for genetic abnormalities in bone marrow and peripher...

Full description

Bibliographic Details
Main Authors: Alberto Quattrocchi, Luca Vincenzo Cappelli, Giovanna De Simone, Elisabetta De Marinis, Martina Gentile, Tecla Gasperi, Alessandro Pulsoni, Paolo Ascenzi, Clara Nervi
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Aspects of Molecular Medicine
Subjects:
Hematopoiesis
Leukemia
AML biomarkers
AML risk classification
Minimal residual disease detection
Epitranscriptome
Online Access:http://www.sciencedirect.com/science/article/pii/S2949688823000230

Internet

http://www.sciencedirect.com/science/article/pii/S2949688823000230

Similar Items